The table below shows Aura Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$29.89M
-$23.36M
-$24.45M
-$16.41M
-$15.20M
-$5.14M
Capital expenditure
$102.00K
$187.00K
$88.00K
$109.00K
$599.00K
$71.00K
Investing cash flow
$54.90M
$29.81M
$9.40M
-$66.88M
-$25.50M
-$71.00K
Dividends paid
-
-
-
-
AURA operating cash flow (10-K history)
Aura Biosciences, Inc. reported operating cash flow of -$84.74M for fiscal year 2025. That is down 6.2% from -$79.81M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$24.32M (FY 2020) to -$84.74M. Figures come from the company's audited annual reports as filed with the SEC.